Chemotherapy for advanced lung cancer

被引：10

作者：

Blackhall, F ^{[1
]}

Thatcher, N ^{[1
]}

机构：

[1] Christie Hosp NHS Trust, Canc Res UK, Dept Med Oncol, Manchester M20 4BX, Lancs, England

来源：

EUROPEAN JOURNAL OF CANCER | 2004年 / 40卷 / 16期

关键词：

D O I：

10.1016/j.ejca.2004.06.026

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：2345 / 2348

页数：4

相关论文

共 21 条

[1] Chemotherapy in advanced nonsmall cell lung cancer: indication, intensity, and duration [J].

Booton, R ;

Thatcher, N .

CURRENT OPINION IN ONCOLOGY, 2002, 14 (02) :191-198

[2] Chemotherapy for advanced non-small-cell lung cancer: Who, what, when, why? [J].

Bunn, PA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :23S-33S

[3]

DADDARIO G, 2003, LUNG CANCER S4, V41, pS68

[4] Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group [J].

Fossella, F ;

Pereira, JR ;

von Pawel, J ;

Pluzanska, A ;

Gorbounova, V ;

Kaukel, E ;

Mattson, KV ;

Ramlau, R ;

Szczesna, A ;

Fidias, P ;

Millward, M ;

Belani, CP .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3016-3024

[5] Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial [J].

Georgoulias, V ;

Papadakis, E ;

Alexopoulos, A ;

Tsiafaki, X ;

Rapti, A ;

Veslemes, M ;

Palamidas, P ;

Vlachonikolis, I .

LANCET, 2001, 357 (9267) :1478-1484

[6] Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group [J].

Gridelli, C ;

Gallo, C ;

Shepherd, FA ;

Illiano, A ;

Piantedosi, F ;

Robbiati, SF ;

Manzione, L ;

Barbera, S ;

Frontini, L ;

Veltri, E ;

Findlay, B ;

Cigolari, S ;

Myers, R ;

Ianniello, GP ;

Gebbia, V ;

Gasparini, G ;

Fava, S ;

Hirsh, V ;

Beziak, A ;

Seymour, L ;

Perrone, F .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3025-3034

[7] Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].

Hanna, N ;

Shepherd, FA ;

Fossella, FV ;

Pereira, JR ;

De Marinis, F ;

von Pawel, J ;

Gatzemeier, U ;

Tsao, TCY ;

Pless, M ;

Muller, T ;

Lim, HL ;

Desch, C ;

Szondy, K ;

Gervais, R ;

Shaharyar ;

Manegold, C ;

Paul, S ;

Paoletti, P ;

Einhorn, L ;

Bunn, PA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597

[8] Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial [J].

Kelly, K ;

Crowley, J ;

Bunn, PA ;

Presant, CA ;

Grevstad, PK ;

Mainpour, CM ;

Ramsey, SD ;

Wozniak, AJ ;

Weiss, GR ;

Moore, DF ;

Israel, VK ;

Livingston, RB ;

Gandara, DR .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3210-3218

[9] Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase III randomized trial [J].

Kosmidis, P ;

Mylonakis, N ;

Nicolaides, C ;

Kalophonos, C ;

Samantas, E ;

Boukovinas, J ;

Fountzilas, G ;

Skarlos, D ;

Economopoulos, T ;

Tsavdaridis, D ;

Papakostas, P ;

Bacoyiannis, C ;

Dimopoulos, M .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3578-3585

[10]

LECHEVALIER T, 2003, LUNG CANCER S4, V41, P70